About Tangible Pharmaceuticals Private Limited
Data last updated:
Tangible Pharmaceuticals Private Limited is a private limited company based in Mirzapur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24239UP2019PTC115051. Its GSTIN is 09AAHCT2405J1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prabha Pandey and Raghvendra Narayan Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Near Singh Button Store Tehsil Road Mahuriya, Mirzapur, Uttar Pradesh, India – 231001.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.89 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹1.42 Lakh (net margin -5.1%) and EBITDA of -₹1.42 Lakh (EBITDA margin -5.1%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
The company is associated with 1 brand: Tangible Pharmaceuticals.
For more details, the company can be reached via its website tangiblepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNear Singh Button Store Tehsil Road Mahuriya, Mirzapur, Uttar Pradesh, India – 231001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Tangible Pharmaceuticals Private Limited
The main business activity of Tangible Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Tangible Pharmaceuticals Private Limited FY 2025 filings available
Tangible Pharmaceuticals Private Limited reported revenue of ₹27.89 Lakh (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Tangible Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 30% fall in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Tangible Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.42 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.42 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Tangible Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tangible Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vvio Pharmaceuticals Private Limited | ₹28.04 Lakh (FY 2023) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Bescheiden Pharmaceuticals Private Limited | ₹28.04 Lakh (FY 2025) | •••• | •••• | 840.0% | •••• | Gmc, Assam, India |
| Shownberg Pharmaceuticals Private Limited | ₹28.01 Lakh (FY 2016) | •••• | •••• | 1006.0% | •••• | Ettumanoor, Kerala, India |
| Medifizer Pharmaceuticals Private Limited | ₹27.95 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Patna, Bihar, India |
| Profam Pharmaceuticals OPC Private Limited | ₹27.93 Lakh (FY 2025) | •••• | •••• | -61.0% | •••• | Gurgaon, Haryana, India |
| Tangible Pharmaceuticals Private Limited this company | ₹27.89 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Mirzapur, Uttar Pradesh, India |
| Neptune Pharmaceuticals Private Limited | ₹27.79 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Srinagar, Jammu and Kashmir, India |
| Oxyon Pharmaceuticals Private Limited | ₹27.79 Lakh (FY 2025) | •••• | •••• | 51.0% | •••• | Burdwan, West Bengal, India |
| Rank Pharmaceuticals Limited | ₹27.73 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Samvee Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2022) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Ceedar Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Kanpur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Tangible Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals Private Limited is audited by PATEL AJEET & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PATEL AJEET & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabha Pandey | Director | 26 Mar 2019 | 7 Years 6 Months | Current |
| Raghvendra Narayan Singh | Director | 26 Mar 2019 | 7 Years 6 Months | Current |
Ownership and Shareholding of Tangible Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals operates one associated brand: Tangible Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations, innovation, and market growth services in India. | tangiblepharma.com |
Employees and EPFO Compliance at Tangible Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Tangible Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Prabha Pandey was appointed as Director on 26 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Tangible Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tangible Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tangible Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCT2405J1ZA | Uttar Pradesh | Active | 23 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tangible Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tangible Pharmaceuticals Private Limited
Tangible Pharmaceuticals is an active private limited company based in Mirzapur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 2019 (7+ years old) and is registered under CIN U24239UP2019PTC115051.
Tangible Pharmaceuticals reported revenue of ₹27.89 Lakh for FY 2025 (down 30% YoY).
Tangible Pharmaceuticals has 2 current directors:
- Prabha Pandey - Director
- Raghvendra Narayan Singh - Director
Tangible Pharmaceuticals reported a net loss of ₹1.42 Lakh (net margin -5.1%) and EBITDA of -₹1.42 Lakh (EBITDA margin -5.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Tangible Pharmaceuticals is -7% over three years and -4% over five years. In the latest year (FY 2025) revenue fell 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Tangible Pharmaceuticals is 09AAHCT2405J1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Tangible Pharmaceuticals is U24239UP2019PTC115051. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tangible Pharmaceuticals was incorporated on 26 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Tangible Pharmaceuticals by revenue are Vvio Pharmaceuticals Private Limited, Bescheiden Pharmaceuticals Private Limited, Shownberg Pharmaceuticals Private Limited, Medifizer Pharmaceuticals Private Limited, Profam Pharmaceuticals OPC Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Prabha Pandey was appointed as Director on 26 Mar 2019. Raghvendra Narayan Singh was appointed as Director on 26 Mar 2019.
Tangible Pharmaceuticals can be reached through the website tangiblepharma.com. Its registered office is in Mirzapur, Uttar Pradesh, India.